1. Home
  2. CRSP vs SPSC Comparison

CRSP vs SPSC Comparison

Compare CRSP & SPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRSP
  • SPSC
  • Stock Information
  • Founded
  • CRSP 2013
  • SPSC 1987
  • Country
  • CRSP Switzerland
  • SPSC United States
  • Employees
  • CRSP N/A
  • SPSC N/A
  • Industry
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • SPSC EDP Services
  • Sector
  • CRSP Health Care
  • SPSC Technology
  • Exchange
  • CRSP Nasdaq
  • SPSC Nasdaq
  • Market Cap
  • CRSP 5.6B
  • SPSC 5.1B
  • IPO Year
  • CRSP 2016
  • SPSC 2010
  • Fundamental
  • Price
  • CRSP $67.35
  • SPSC $112.51
  • Analyst Decision
  • CRSP Buy
  • SPSC Buy
  • Analyst Count
  • CRSP 18
  • SPSC 11
  • Target Price
  • CRSP $73.47
  • SPSC $156.18
  • AVG Volume (30 Days)
  • CRSP 2.7M
  • SPSC 358.7K
  • Earning Date
  • CRSP 11-04-2025
  • SPSC 10-30-2025
  • Dividend Yield
  • CRSP N/A
  • SPSC N/A
  • EPS Growth
  • CRSP N/A
  • SPSC 13.55
  • EPS
  • CRSP N/A
  • SPSC 2.18
  • Revenue
  • CRSP $38,050,000.00
  • SPSC $703,542,000.00
  • Revenue This Year
  • CRSP N/A
  • SPSC $21.81
  • Revenue Next Year
  • CRSP $391.94
  • SPSC $9.15
  • P/E Ratio
  • CRSP N/A
  • SPSC $51.57
  • Revenue Growth
  • CRSP N/A
  • SPSC 20.51
  • 52 Week Low
  • CRSP $30.04
  • SPSC $102.05
  • 52 Week High
  • CRSP $78.48
  • SPSC $201.06
  • Technical
  • Relative Strength Index (RSI)
  • CRSP 50.50
  • SPSC 57.12
  • Support Level
  • CRSP $64.80
  • SPSC $110.75
  • Resistance Level
  • CRSP $75.06
  • SPSC $113.71
  • Average True Range (ATR)
  • CRSP 4.55
  • SPSC 3.05
  • MACD
  • CRSP -0.96
  • SPSC 0.84
  • Stochastic Oscillator
  • CRSP 18.64
  • SPSC 78.60

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About SPSC SPS Commerce Inc.

SPS Commerce Inc is a provider of cloud-based supply chain management services for retailers, grocers, distributors, suppliers, and logistics firms to increase supply chain performance, optimize inventory levels and sell-through, reduce operational costs, improve order visibility, and satisfy consumer demands for a seamless omnichannel experience. Its solutions are delivered through the SPS Commerce platform and provide integrations and retail performance analytics to its customers. Its products are; Fulfillment, Analytics, and Other products like Assortment and Community also it provides one-time services such as professional services and testing and certification. The group derives revenue from subscription-based recurring revenue services.

Share on Social Networks: